Ascend Therapeutics
Private Company
Total funding raised: $90M
Overview
Ascend Therapeutics is a private, commercial-stage specialty pharma company concentrating on hormone replacement therapies. Founded in 1999 and headquartered in Herndon, Virginia, it serves as the US subsidiary of Besins Healthcare, a global leader with a long history in hormone science. The company's business model is centered on commercializing Besins' portfolio of approved small-molecule hormone products, primarily in women's health and endocrinology. It is a revenue-generating entity focused on marketing and medical support for its established therapeutic products.
Technology Platform
Commercialization platform leveraging the inherited hormone therapy expertise, manufacturing, and product portfolio of parent company Besins Healthcare, specializing in natural progesterone and estradiol formulations.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Ascend operates in the competitive Hormone Replacement Therapy market, competing against large pharmaceutical companies (e.g., Pfizer, Novartis) with major brands, as well as numerous generic manufacturers. Its differentiation lies in its specialized focus on hormones, the legacy of Besins' expertise in natural/bio-identical formulations, and its position as a dedicated subsidiary rather than a division within a large conglomerate.